Hostname: page-component-7b7567c8c-tnkh4 Total loading time: 0 Render date: 2026-11-16T02:29:31.983Z Has data issue: false hasContentIssue false

Changes in the microbiology, epidemiology, and outcomes of candidemia in Connecticut: A comparison between two periods using statewide surveillance

Published online by Cambridge University Press:  25 August 2022

Johanna R. Gleason-Vergados
Affiliation:
University of Connecticut School of Medicine, Farmington, Connecticut
Paula Clogher
Affiliation:
Connecticut Emerging Infections Program, Yale School of Public Health, New Haven, Connecticut
James I. Meek
Affiliation:
Connecticut Emerging Infections Program, Yale School of Public Health, New Haven, Connecticut
David B. Banach*
Affiliation:
University of Connecticut School of Medicine, Farmington, Connecticut
*
Author for correspondence: David B. Banach, E-mail: DBanach@uchc.edu
Rights & Permissions [Opens in a new window]

Abstract

Using statewide surveillance, we describe candidemia in Connecticut during 1998–2000 and 2019. In 2019, candidemia was more frequently associated with community-onset and non-albicans Candida species and less frequently associated with central vascular catheters, recent surgery, and in-hospital mortality. Understanding changes in candidemia can optimize clinical management and prevention strategies.

Information

Type
Concise Communication
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
Figure 0

Table 1.Candida Species Isolated from Blood Cultures of Candidemia Cases in Connecticut Adults from 1998–2000 and 2019

Figure 1

Table 2.Characteristics and Outcomes of Candidemia in Connecticut Adults, 1998–2000 and 2019